conditioning hair treatment

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• For gels and serums, the recorded level is 3–8% for the formula.
• 2–5% is listed for creams in this reference.
• For rinse-off, the reference gives 2–4% in this reference.

The guide places Glycerin in the water phase and calls for no melt step.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• The framework in Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Glycerin is used for the completed formula, not simply for an ingredient in isolation.
• Confirm the received Glycerin grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; it provides no evidence that a drug or OTC monograph applies so assess patch response and stability in the final formula.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Glycerin emphasizes humectant function.

• This ingredient reference does not substantiate drug effects, clinical cures, or unsupported product certifications.
• The ingredient note for Glycerin does not demonstrate whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

This reference identifies squalane as a stable hydrocarbon emollient and calls for a plant-derived grade, not mineral oil.

3. Typical use levels (formulation guide)

• The stated reference for gel-creams is 2–6% for the formula.
• The level shown for dry oils is 10–30%.
• The stated reference for balms is 5–15%.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• The CosIng record for Squalane, where listed, is informational rather than product-specific authorization.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Squalane as it will be marketed for the complete formula intended for sale.
• For Squalane, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; it does not authorize a drug or OTC product so patch response and stability should be checked on the finished product.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; review airless or pump options if oxidation presents a concern; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• This ingredient reference cannot substantiate claims of drug activity, a clinical cure, or an undocumented product certification.
• The Squalane entry cannot verify skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Shea butter is included as a triglyceride butter for cushioning creams, balms, and hair creams; unrefined color and fragrance are not assumed.

3. Typical use levels (formulation guide)

• For creams, the reference gives 2–8% as a formulation guide.
• Formulation guidance for balms and butters: 10–25%.

Melt Butyrospermum Parkii Butter into the oil phase, then cool under shear to help prevent graininess.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Butyrospermum Parkii Butter as a reference only; verify the grade and intended use under current market rules.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the completed product containing Butyrospermum Parkii Butter to receive its own safety assessment as a finished-product assessment.
• For Butyrospermum Parkii Butter, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; no drug approval or OTC-monograph status follows from this guide so patch response and stability should be checked on the finished product.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; if the formula is oxidation-sensitive, an airless or pump format may be considered; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The cosmetic role of Butyrospermum Parkii Butter is presented as shea cushion.

• This product entry does not support drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The formulation record for Butyrospermum Parkii Butter does not support whitening, treatment of acne, perspiration control, sun protection, or hair growth.